Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manlio Tolomeo

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|May 12, 2006
Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cellsMarinella Roberti, Daniela Pizzirani, Maurizio Recanatini, et al.
European Journal of Medicinal Chemistry|April 16, 2015
Synthesis and antiproliferative activity of 3-(2-chloroethyl)-5-methyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4-(3H)-oneBenedetta Maggio, Maria Valeria Raimondi, Demetrio Raffa, et al.
Chemmedchem|December 29, 2007
Antiproliferative agents that interfere with the cell cycle at the G1-->S transition: further development and characterization of a small library of stilbene-derived compoundsDaniela Pizzirani, Marinella Roberti, Andrea Cavalli, et al.
Anti-Cancer Drugs|February 2, 2013
The new iodoacetamidobenzofuran derivative TR120 decreases STAT5 expression and induces antitumor effects in imatinib-sensitive and imatinib-resistant BCR-ABL-expressing leukemia cellsStefania Grimaudo, Maria Meli, Antonietta Di Cristina, et al.
European Journal of Medicinal Chemistry|March 15, 2008
Synthesis and induction of G0-G1 phase arrest with apoptosis of 3,5-dimethyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4(3H)-oneBenedetta Maggio, Demetrio Raffa, Maria Valeria Raimondi, et al.
Le Infezioni in Medicina|March 5, 2021
Clinical use of BCG and its complications: a case seriesClaudia Colomba, Raffaella Rubino, Gabriele Mantia, et al.
International Journal of Oncology|February 15, 2011
Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3'-C-methyladenosine in leukaemia cellsMaria Meli, Manlio Tolomeo, Mario Grifantini, et al.
Journal of Infection and Public Health|September 20, 2023
Causes of hospitalization and predictors of in-hospital mortality among people living with HIV in Sicily-Italy between 2010 and 2021Luca Pipitò, Giuseppe Zinna, Marcello Trizzino, et al.
BMC Infectious Diseases|December 17, 2009
Cryptic Leishmania infantum infection in Italian HIV infected patientsClaudia Colomba, Laura Saporito, Fabrizio Vitale, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Synthesis of novel antimitotic agents based on 2-amino-3-aroyl-5-(hetero)arylethynyl thiophene derivativesRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|May 12, 2006
Identification of a terphenyl derivative that blocks the cell cycle in the G0-G1 phase and induces differentiation in leukemia cellsMarinella Roberti, Daniela Pizzirani, Maurizio Recanatini, et al.
European Journal of Medicinal Chemistry|April 16, 2015
Synthesis and antiproliferative activity of 3-(2-chloroethyl)-5-methyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4-(3H)-oneBenedetta Maggio, Maria Valeria Raimondi, Demetrio Raffa, et al.
Chemmedchem|December 29, 2007
Antiproliferative agents that interfere with the cell cycle at the G1-->S transition: further development and characterization of a small library of stilbene-derived compoundsDaniela Pizzirani, Marinella Roberti, Andrea Cavalli, et al.
Anti-Cancer Drugs|February 2, 2013
The new iodoacetamidobenzofuran derivative TR120 decreases STAT5 expression and induces antitumor effects in imatinib-sensitive and imatinib-resistant BCR-ABL-expressing leukemia cellsStefania Grimaudo, Maria Meli, Antonietta Di Cristina, et al.
European Journal of Medicinal Chemistry|March 15, 2008
Synthesis and induction of G0-G1 phase arrest with apoptosis of 3,5-dimethyl-6-phenyl-8-(trifluoromethyl)-5,6-dihydropyrazolo[3,4-f][1,2,3,5]tetrazepin-4(3H)-oneBenedetta Maggio, Demetrio Raffa, Maria Valeria Raimondi, et al.
Le Infezioni in Medicina|March 5, 2021
Clinical use of BCG and its complications: a case seriesClaudia Colomba, Raffaella Rubino, Gabriele Mantia, et al.
International Journal of Oncology|February 15, 2011
Histone deacetylase inhibition modulates deoxyribonucleotide pools and enhances the antitumor effects of the ribonucleotide reductase inhibitor 3'-C-methyladenosine in leukaemia cellsMaria Meli, Manlio Tolomeo, Mario Grifantini, et al.
Journal of Infection and Public Health|September 20, 2023
Causes of hospitalization and predictors of in-hospital mortality among people living with HIV in Sicily-Italy between 2010 and 2021Luca Pipitò, Giuseppe Zinna, Marcello Trizzino, et al.
BMC Infectious Diseases|December 17, 2009
Cryptic Leishmania infantum infection in Italian HIV infected patientsClaudia Colomba, Laura Saporito, Fabrizio Vitale, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2010
Synthesis of novel antimitotic agents based on 2-amino-3-aroyl-5-(hetero)arylethynyl thiophene derivativesRomeo Romagnoli, Pier Giovanni Baraldi, Olga Cruz-Lopez, et al.
Pageof 8